Research Paper Volume 16, Issue 5 pp 4699—4722
SUMF1 overexpression promotes tumorous cell growth and migration and is correlated with the immune status of patients with glioma
Figure 1. SUMF1 expression levels in glioma. (A) Normal vs. glioma in TCGA database; (B) Normal vs. glioma in the XNEA database; (C) Wild-type vs. mutant in IDH status; (D) Non-codel vs. codel in 1p/19q codeletion; (E) Female vs. Male in sex; (F) ≤60 vs. >60 in age; (G) Astrocytoma vs. oligoastrocytoma; (H) Astrocytoma vs. oligodendroglioma; (I) Astrocytoma vs. glioblastoma; (J) Oligoastrocytoma vs. oligodendroglioma; (K) Oligoastrocytoma vs. glioblastoma; (L) Oligodendroglioma vs. glioblastoma; (M) Alive vs. dead in OS; (N, O) No vs. yes in DSS and PFI. Abbreviations: DSS: disease-specific survival; IDH: isocitrate dehydrogenase; OS: overall survival; PFI: progression-free interval.